By Dean Seal Shares of Iovance hit a 52-week high after the company's $211 million underwritten offering was priced and it announced key approvals from.
By Dean Seal Shares of Iovance hit a 52-week high after the company s $211 million underwritten offering was priced and it announced key approvals from regulators for Amtagvi. The stock.